|
Category :
Company News
Headline :
GlaxoSmithKline Phar - Board Meeting Intimation for \r\nAudited Financial Results For Year 31St March 2024 & To Recommend Div
Date:
19/04/2024 12:14
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve \r\nPursuant to clause 29 & 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Friday, 17th May 2024, inter-alia, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended 31st March 2024 and to recommend dividend, if any, on the equity shares of the Company.\r\n
|